Clinical trial

Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and…

NCT00199732 · University Hospital, Limoges, Other · Completed

Key facts

NCT number NCT00199732
Title Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a
Official title Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a
Acronym DNA-EVAL
Lead sponsor University Hospital, Limoges, Other
Collaborators Hoffmann-La Roche Industry
Status Completed
Study type Observational
Conditions Chronic Hepatitis B
Enrollment 19
Start date Dec 1, 2004
Primary completion Jul 1, 2009
Completion Jul 1, 2009
First posted Sep 20, 2005
Last update posted Apr 17, 2013
Countries France

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies